Markets:

Overview

News

Currencies

International

Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

6.200 +0.120 (+1.97%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Unicycive Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 06, 2023

Via Benzinga

Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket ↗

January 03, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 29, 2022

Via Benzinga

Unicycive Therapeutics' Geographic Atrophy Candidate Shows Improved Contrast Vision In Animal Studies ↗

November 21, 2022

Via Benzinga

Unicycive Inks Licensing Pact For Its Kidney Disease Candidate In China ↗

July 18, 2022

Via Benzinga

Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗

December 30, 2022

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...

Via Benzinga

Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket ↗

December 29, 2022

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 125% to $0.54 in pre-market trading after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the...

Via Benzinga

Nasdaq Down 100 Points; Kala Pharmaceuticals Shares Spike Higher ↗

December 28, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Wednesday.

Via Benzinga

Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗

December 28, 2022

Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 28, 2022

Via Benzinga

Dow Tumbles 150 Points; Crude Oil Falls Sharply ↗

December 28, 2022

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Wednesday.

Via Benzinga

Unicycive Shares Jump As Renazorb Achieves Primary Endpoint In Bioequivalence Study ↗

December 28, 2022

Via Benzinga

Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive ↗

December 07, 2022

In the U.S., reimbursement of dialysis expenses by the Centers for Medicare & Medicaid Services (CMS) is done using a prospective payment system (PPS) which enables the payout of a predetermined amount...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 04, 2022

Gainers

Via Benzinga

Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells

October 12, 2022

By David Willey, Benzinga

Via News Direct

Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells ↗

October 11, 2022

You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?

Via Benzinga

How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication ↗

September 22, 2022

Most people are surprised to learn that chronic kidney disease (CKD) is the fastest growing, non-communicable disease in the United States. 37 million American adults have CKD and more than 600,000...

Via Benzinga

The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine ↗

July 18, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022 ↗

June 08, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 04, 2022

Gainers 1Life Healthcare (NASDAQ:ONEM) shares moved upwards by 22.4% to $9.58 during Wednesday's after-market session. The market value of their outstanding shares is at $1.8 billion. The company's, Q1...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 02, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 27, 2022

Gainers Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 9.9% to $1.0 during Wednesday's after-market session. The company's market cap stands at $15.0 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 29, 2022

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 45.0% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $8.5 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 17, 2022

Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 31.0% to $1.31 during Thursday's pre-market session. The company's market cap stands at $36.7 million....

Via Benzinga

22 Stocks Moving in Thursday's Pre-Market Session ↗

March 17, 2022

Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 81.2% to $0.43 in pre-market trading after the company reported FY21 results. Orphazyme A/S (NASDAQ: ORPH) shares rose 35.1% to $0....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022 ↗

March 16, 2022

Upgrades Bernstein upgraded the previous rating for Stryker Corp (NYSE:SYK) from Market Perform to Outperform. For the fourth quarter, Stryker had an EPS of $2.71, compared to...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 15, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) stock moved upwards by 92.3% to $44.04 during Tuesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 24, 2022

Gainers Unicycive Therapeutics (NASDAQ:UNCY

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 08, 2022

Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

Headline News about Unicycive Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today